RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jun. 6, 2019-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Raymond James Life Sciences and Medtech Conference at The Lotte New York Palace in New York City. The presentation is scheduled to take place at 9:10 AM Eastern, Wednesday, June 19, 2019.

About TransEnterix

TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The Company is focused on the commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery. The system allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. The Senhance Surgical System is available for sale in the US, the EU, Japan and select other countries. For more information, visit www.transenterix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005046/en/

Source: TransEnterix, Inc.

TransEnterix, Inc.
Investor Contact:
Mark Klausner, 443-213-0501
transenterix@westwicke.com
or
Media Contact:
Joanna Rice, 951-751-1858
joanna@greymattermarketing.com